Search…

Lates News

29/08/2025

Every AI Express, Pacific Securities released a research report on August 29, giving Hongbo Pharmaceutical (301230.SZ) a buy rating. The reasons for the rating mainly include: 1) market demand is picking up, with strong performance growth; 2) rapid growth in commercial production revenue, continuously improving profitability; 3) Q2 new signed orders improved month-on-month, with continuous growth in customer numbers. (Daily Economic News)

Latest

2 m ago

Sanfu Outdoors: Net profit in the first half of 2025 increased by 105.75% year-on-year.

2 m ago

Tianyu Corporation: Subsidiary's formulated product obtains first FDA approval number in the United States

2 m ago

According to a news flash from Every Economic News, Guosen Securities released a research report on August 29, giving neutral rating to Sunong Bank (603323.SH). The reasons for this rating include: 1) Revenue continues to increase positively, with performance growth exceeding 5%; 2) Size continues to expand, with midterm dividends distributed; 3) Net interest margin continues to narrow, with improvements on the liability side; 4) Non-interest net income grows year-on-year, with impressive investment income performance; 5) Asset quality remains robust.

2 m ago

Si Quan New Materials: Currently, the company's liquid cooling products are in the sample testing stage and there is significant uncertainty in the progress of related business.

3 m ago

Wuyi, China: a net loss of 92.99 million CNY in the first half of 2025.

See all latest